4.3 Article

High Incidence of Partial Biotinidase Deficiency in the First 3 Years of a Regional Newborn Screening Program in Italy

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Biotinidase activity is affected by both seasonal temperature and filter collection cards

Matthew P. A. Henderson et al.

Summary: This study aimed to investigate pre-analytical factors that affect the frequency of positive results in newborn screening for biotinidase deficiency. The study found that seasonal temperature changes and the use of newly printed filter cards for sample collection can impact the determination of biotinidase activity.

CLINICAL BIOCHEMISTRY (2023)

Article Endocrinology & Metabolism

Recovery of enzyme activity in biotinidase deficient individuals during early childhood

Patrick Forny et al.

Summary: Biotinidase (BTD) deficiency is a congenital metabolic disorder caused by defects in the BTD gene. Partial BTD deficiency patients show increased BTD enzyme activity with age, allowing some individuals to stop biotin supplementation. Genetic testing reveals different variants and genotypes, with p.(Asp444His) being the most common variant in patients showing recovery of enzyme activity. Retesting all partial BTD deficiency patients at the age of 5 can impact therapy, and genetic testing can predict the severity of BTD deficiency and the likelihood of enzyme activity recovery.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Endocrinology & Metabolism

Evaluation of the efficiency of serum biotinidase activity as a newborn screening test in Turkey

Mujgan Ercan et al.

Summary: The study aimed to evaluate the impact of genetic mutations on biochemical enzyme activity and identify the correlation between genotype and biochemical phenotype. Results showed a 93.98% conformity between biochemical phenotype and genotype in the cases studied.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2021)

Article Environmental Sciences

Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening

Ilaria Cicalini et al.

Summary: BTD deficiency is an autosomal recessive inherited neurocutaneous disorder that affects enzyme activity and secondary alterations in the metabolism of amino acids, carbohydrates, and fatty acids. Newborn screening can detect BTD deficiency, and it can be classified as profound or partial.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Pediatrics

Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy

Alice Maguolo et al.

Summary: This study presents the experience in diagnosis, treatment, and follow-up of BD patients in Verona, Italy, highlighting the impact of newborn screening and the increased incidence. It reveals that partial BD is more common than profound BD, with controversial treatment options. Sharing experiences is crucial in achieving guidelines for treatment and follow-up, and improving the genotype-phenotype correlation.

FRONTIERS IN PEDIATRICS (2021)

Article Public, Environmental & Occupational Health

Frequency of biotinidase gene variants and incidence of biotinidase deficiency in the Newborn Screening Program in Minas Gerais, Brazil

Nara de Oliveira Carvalho et al.

JOURNAL OF MEDICAL SCREENING (2020)

Article Genetics & Heredity

High frequency of biotinidase deficiency in Italian population identified by newborn screening

Silvia Funghini et al.

MOLECULAR GENETICS AND METABOLISM REPORTS (2020)

Review Endocrinology & Metabolism

Biotin in metabolism, gene expression, and human disease

Alfonso Leon-Del-Rio

JOURNAL OF INHERITED METABOLIC DISEASE (2019)

Article Genetics & Heredity

Novel mutations causing biotinidase deficiency in individuals identified by the newborn screening program in Minas Gerais, Brazil

Nara O. Carvalho et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Article Endocrinology & Metabolism

Single center experience of biotinidase deficiency: 259 patients and six novel mutations

Ebru Canda et al.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2018)

Article Genetics & Heredity

Neonatal screening for biotinidase deficiency: A 30-year single center experience

Francesco Porta et al.

MOLECULAR GENETICS AND METABOLISM REPORTS (2017)

Article Biochemistry & Molecular Biology

Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations

Rachel C. Wiltink et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2016)

Article Biochemistry & Molecular Biology

COMPARISON OF SPECTROPHOTOMETRIC AND FLUORIMETRIC METHODS IN EVALUATION OF BIOTINIDASE DEFICIENCY

Sevgin Ozlem Iseri-Erten et al.

JOURNAL OF MEDICAL BIOCHEMISTRY (2016)

Article Endocrinology & Metabolism

Biotinidase deficiency: Spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007-2014)

Srinitya Gannavarapu et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Editorial Material Endocrinology & Metabolism

Why screen newborns for profound and partial biotinidase deficiency?

Barry Wolf

MOLECULAR GENETICS AND METABOLISM (2015)

Article Endocrinology & Metabolism

Biotinidase deficiency should be considered in individuals exhibiting myelopathy with or without and vision loss

Barry Wolf

MOLECULAR GENETICS AND METABOLISM (2015)

Article Genetics & Heredity

Analysis of Mutations Causing Biotinidase Deficiency

Kirit Pindolia et al.

HUMAN MUTATION (2010)

Review Endocrinology & Metabolism

Clinical issues and frequent questions about biotinidase deficiency

Barry Wolf

MOLECULAR GENETICS AND METABOLISM (2010)

Article Endocrinology & Metabolism

Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases

T Baykal et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2005)

Article Pediatrics

The magnitude and challenge of false-positive newborn screening test results

C Kwon et al.

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2000)